Effects of cilnidipine, a novel dihydropyridine calcium antagonist, on autonomic function, ambulatory blood pressure and heart rate in patients with essential hypertension

被引:33
|
作者
Minami, J [1 ]
Kawano, Y
Makino, Y
Matsuoka, H
Takishita, S
机构
[1] Dokkyo Univ, Sch Med, Dept Med, Div Hypertens & Cardiorenal Dis, Mibu, Tochigi 3210293, Japan
[2] Natl Cardiovasc Ctr, Div Nephrol & Hypertens, Osaka 5650873, Japan
关键词
ambulatory blood pressure; autonomic function; calcium antagonist; cilnidipine; cold presser; heart rate variability; heart rate;
D O I
10.1046/j.1365-2125.2000.00299.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aims The aim of the present study was to evaluate the effects of cilnidipine, a novel dihydropyridine calcium antagonist, on autonomic function, ambulatory blood pressure and heart rate in patients with essential hypertension. Methods Ten inpatients with mild to moderate essential hypertension (four men and six women; age: 44-64 years) underwent a drug-free period for 7 days and a treatment period with cilnidipine 10 mg orally for another 7 days, in a randomized crossover study. On the sixth day of each period, they underwent autonomic function tests including a mental arithmetic test, a cold presser test and a Valsalva manoeuvre. After these tests, 24 h ambulatory blood pressure, heart rate, and the electrocardiogram R-R intervals were monitored every 30 min. A power spectral analysis of R-R intervals was performed to obtain the low-and high-frequency components. Results Cilnidipine significantly decreased the 24 h blood pressure by 6.5 +/- 1.7 mm Hg systolic (mean+/-s.e.mean; P<0.01) and 5.0+/-1.1 mmHg diastolic (P<0.01), whereas cilnidipine did not change heart rate or any indices of power spectral components. During the cold presser test, the maximum change in systolic blood pressure and percentage changes in both systolic and diastolic blood pressures were significantly lower during the treatment period with cilnidipine than during the drug-free period. The baroreflex sensitivity measured from the overshoot phase of the Valsalva manoeuvre did not differ significantly between the two periods. Conclusions Cilnidipine is effective as a once-daily antihypertensive agent and causes little influence on heart rate and the autonomic nervous system in patients with mild to moderate essential hypertension. Moreover, it is suggested that cilnidipine has an additional clinical benefit in the inhibition of the presser response induced by acute cold stress.
引用
收藏
页码:615 / 620
页数:6
相关论文
共 50 条
  • [21] Effects of slow breathing rate on blood pressure and heart rate variabilities in essential hypertension
    Chang, Qinghua
    Li, Changjun
    Liu, Renguang
    Shen, Zhongyuan
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (16) : C139 - C140
  • [22] Effects of slow breathing rate on blood pressure and heart rate variabilities in essential hypertension
    Chang, Qinghua
    Liu, Renguang
    Li, Changjun
    Shen, Zhongyuan
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 185 : 52 - 54
  • [23] Comparison of the effects of L-type calcium channel antagonist Amlodipine with L/N-type calcium channel antagonist Cilnidipine on blood pressure, heart rate, proteinuria and lipid profile in hypertensive patients
    Singal, K. K.
    Singal, N.
    Gupta, A.
    Garg, A.
    Kumar, R.
    BANGLADESH JOURNAL OF MEDICAL SCIENCE, 2016, 15 (03): : 460 - 465
  • [24] Effects of a walking program on blood pressure, heart rate and cardiac autonomic function in men and women with mild hypertension
    Hua, Lien
    Brown, C. Ann
    Hains, Sylvia
    Godwin, Marshall
    Parlow, Joel
    CANADIAN JOURNAL OF CARDIOLOGY, 2007, 23 : 329C - 329C
  • [25] Comparison between cilnidipine and nisoldipine with respect to effects on blood pressure and heart rate in hypertensive patients
    Minami, J
    Ishimitsu, T
    Higashi, T
    Numabe, A
    Matsuoka, H
    HYPERTENSION RESEARCH-CLINICAL AND EXPERIMENTAL, 1998, 21 (03): : 215 - 219
  • [26] Assessment of heart rate variability after calcium antagonist and β-blocker therapy in patients with essential hypertension
    Rabbia, F
    Martini, G
    Sibona, MP
    Grosso, T
    Simondi, F
    Chiandussi, L
    Veglio, F
    CLINICAL DRUG INVESTIGATION, 1999, 17 (02) : 111 - 118
  • [27] Assessment of Heart Rate Variability after Calcium Antagonist and β-Blocker Therapy in Patients with Essential Hypertension
    Franco Rabbia
    Gianpiero Martini
    Maria Pia Sibona
    Tiziana Grosso
    Fabrizio Simondi
    Livio Chiandussi
    Franco Veglio
    Clinical Drug Investigation, 1999, 17 : 111 - 118
  • [28] Effects of felodipine ER, a dihydropyridine calcium antagonist, on blood pressure and serum lipids
    Reuter, MK
    Lorenz, H
    Verho, P
    Smith, N
    Degen, A
    Verho, M
    CURRENT MEDICAL RESEARCH AND OPINION, 1998, 14 (02) : 97 - 103
  • [29] Efficacy of Valsartan on ambulatory blood pressure in patients with essential hypertension
    Li, DB
    Hua, Q
    AMERICAN JOURNAL OF HYPERTENSION, 2003, 16 (05) : 54A - 54A
  • [30] Effects of impaired glucose metabolism on heart rate variability and blood pressure variability in essential hypertension patients
    Wang G.
    Journal of Huazhong University of Science and Technology, 2006, 26 (6): : 654 - 656